Urban wetland parks in Finland: improving water quality and creating endangered habitats

Urbanization changes water balance, degrades water quality and disrupts habitats. Wetlands offer storm water volume and flow control, water pollution mitigation, and rich land–water interphase habitats. In the present case study, urban wetlands were designed and implemented to provide multiple functions, including water quality improvement and the establishment of critically endangered clay stream habitat, along a revived urban stream within the Baltic Sea watershed in Southern Finland. The primary water quality concern in the recipient lake is algal bloom controlling and clay particle-carried phosphorus. Wetlands were monitored for functioning over five calendar years. At a wetland monitored for 5 years, herbaceous vegetation was well self-established in the second year, and reached 102 species, of which 97% were native, in the fifth growing season. Successful breeding of amphibians and water birds occurred right after construction. Continuous water quality monitoring over the fourth year at this wetland, with 0.1% area of its watershed, revealed seasonal and event-based differences: for total phosphorus, an annual 10% average with lower removal rates outside, and up to 71% event reductions during the growing season, while highest load reductions occurred during heavy rain and snowmelt events outside the growing season. The created wetlands provided critical habitat and beneficial functions and thus compensated partly for urbanization.Peer reviewe

Report on the implementation of the nitrates directive in Finland

Luku 1 on myös suomeksi (Chapter 1 is also available in Finnish)

Fecal microbiome alterations in treatment-naive de novo Parkinson's disease

Gut microbiota alterations in Parkinson's disease (PD) have been found in several studies and are suggested to contribute to the pathogenesis of PD. However, previous results could not be adequately adjusted for a potential confounding effect of PD medication and disease duration, as almost all PD participants were already using dopaminergic medication and were included several years after diagnosis. Here, the gut microbiome composition of treatment-naive de novo PD subjects was assessed compared to healthy controls (HC) in two large independent case-control cohorts (n = 136 and 56 PD, n = 85 and 87 HC), using 16S-sequencing of fecal samples. Relevant variables such as technical batches, diet and constipation were assessed for their potential effects. Overall gut microbiome composition differed between PD and HC in both cohorts, suggesting gut microbiome alterations are already present in de novo PD subjects at the time of diagnosis, without the possible confounding effect of dopaminergic medication. Although no differentially abundant taxon could be replicated in both cohorts, multiple short chain fatty acids (SCFA) producing taxa were decreased in PD in both cohorts. In particular, several taxa belonging to the family Lachnospiraceae were decreased in abundance. Fewer taxonomic differences were found compared to previous studies, indicating smaller effect sizes in de novo PD.</p